The ability of combined treatment with AZD1390 and radiation to enhance interferon-stimulated gene Cxcl9, Cxcl10, and PD-L1 expression was confirmed in two murine pancreatic adenocarcinoma lines, mT4 and KPC2 (Figure 1, F–H, and Supplemental Figure 1, A–C; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.168824DS1). The gene discussed is CXCL9; the disease is pancreatic adenocarcinoma.